CIK 0001400118
- Emerging growth company
Sagimet Biosciences Inc.
Sign in to watch- Ticker
- SGMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205991472
- Phone
- +1 650-561-8600
- Business address
- 950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
- Former names
- 3-V Biosciences, Inc.
- 4 Grant or award Chief Financial Officer acquired 44,000 shares (grant or award)
- 4 Open-market sale President & CEO sold 12,101 shares at $5.36 ($64,865)
- 4 Open-market sale Chief Financial Officer sold 1,312 shares at $5.36 ($7,033)
- 4 Open-market sale Chief Medical Officer sold 3,640 shares at $5.36 ($19,511)
- 4 Open-market sale Chief Legal & Admin. Officer sold 2,622 shares at $5.36 ($14,054)
- 4 Planned sale Executive Chairman sold 37,688 shares at $7.69 ($289,979)
- 4 Grant or award Chief Legal & Admin. Officer acquired 9,855 shares (grant or award)
- 4 Open-market sale President & CEO sold 65,478 shares at $9.13 ($598,115)
- 4 Open-market sale Chief Medical Officer sold 8,277 shares at $9.13 ($75,607)
- 4 Open-market sale General Counsel and CCO sold 10,780 shares at $9.13 ($98,471)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 116,000 shares (grant or award)
- 4 Grant or award General Counsel and CCO acquired 34,000 shares (grant or award)
Page 2 of 5 · 100 filings